Neuralink Faces Challenges with Brain Implant Wires in First Human Trial

Elon Musk's neurotech company knew of potential issues with its brain chip's wires retracting from the brain, which impacted the device's effectiveness.

Neuralink's first human patient experienced wire retraction weeks after the implant was inserted.
The company had known about the risk of wire retraction from earlier animal tests.
Adjustments to the device's algorithm improved its sensitivity and functionality.
The FDA was aware of the potential issue when it approved the human trials.
Neuralink plans to implant devices in 10 more patients by the end of the year.